We are live on ! Find out more
FENC icon

Fennec Pharmaceuticals

119 hedge funds and large institutions have $191M invested in Fennec Pharmaceuticals in 2026 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 37 increasing their positions, 32 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

214% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 7

156% more capital inflows, than outflows

Capital inflows: $30.4M | Capital outflows: $11.9M

16% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 32

13% more funds holding

Funds holding: 105 → 119 (+14)

4.5% more ownership

Funds ownership: 46.77% → 51.27% (+4.5%)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

Holders
119
Holders Change
+14
Holders Change %
+13.33%
% of All Funds
1.45%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
22
Increased
37
Reduced
32
Closed
7
Calls
$168​K
Puts
–
Net Calls
+$168​K
Net Calls Change
-⁠$216​K

FENC Hedge Fund Activity: Q3 2026 in Review

119 of the 8,227 institutional investors tracked by Wall St. Rank reported a position in Fennec Pharmaceuticals (FENC) for Q3 2026, worth a combined $191M — up 9.3% from $175M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new FENC positions and 7 closed out — a net gain of 15 holders — while 37 added to existing stakes and 32 trimmed.

The largest buyer was Prospect Capital Advisors, adding an estimated $4.27M. The largest seller was Solas Capital Management, cutting an estimated $5.01M.

  • 119 institutional investors held Fennec Pharmaceuticals (FENC) as of Q3 2026, up from 105 in Q2 2026.
  • Funds reported $191M of Fennec Pharmaceuticals stock for Q3 2026, up 9.3% quarter-over-quarter.
  • 22 funds opened new Fennec Pharmaceuticals positions in Q3 2026 and 7 closed out, a net change of +15 holders.
  • The largest Fennec Pharmaceuticals buyer in Q3 2026 was Prospect Capital Advisors, an estimated $4.27M added.
  • The largest Fennec Pharmaceuticals seller in Q3 2026 was Solas Capital Management, an estimated $5.01M sold.

Based on aggregated 13F filings for Q3 2026.